Skip to main content
Top

A Glass of Water Immediately Increases Gastric pH in Healthy Subjects

  • 01-12-2008
  • Original Paper
Published in:

Abstract

Onset of action of antisecretory agents is of pivotal importance for patients with gastroesophageal reflux disease (GERD) treated “on-demand.” Aim To study the acute effect of acid-inhibiting drugs and water administration on gastric pH. Method A cross-over study was performed in 12 H. pylori (-), healthy subjects (6 men; mean age: 26 years). A single oral dose of the following agents was received with a wash-out period between each study: a glass of water (200 ml), antacid, ranitidine, omeprazole, esomeprazole, and rabeprazole. Gastric pH was recorded for 6 h after drug intake. Results Water increased gastric pH >4 in 10/12 subjects after 1 min. The time (median) needed to pH >4 was for: antacid 2 min, ranitidine 50 min, omeprazole 171 min, esomeprazole 151 min, and rabeprazole 175 min. Gastric pH >4 lasted for 3 min after water and for 12 min after antacids; it remained >4 until the end of recording in: 4/12 subjects with ranitidine, 11/12 with rabeprazole, and all with omeprazole and esomeprazole. Conclusion Water and antacid immediately increased gastric pH, while PPIs showed a delayed but prolonged effect compared to ranitidine.
Title
A Glass of Water Immediately Increases Gastric pH in Healthy Subjects
Authors
George Karamanolis
Ioanna Theofanidou
Marina Yiasemidou
Evangelos Giannoulis
Konstantinos Triantafyllou
Spiros D. Ladas
Publication date
01-12-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0301-3
This content is only visible if you are logged in and have the appropriate permissions.
SPONSORED

Adherence to injectables

In this podcast, Professor Jorge Sánchez shares his insights into identifying and addressing poor adherence to injectable therapy, offering guidance that can help to support patients with chronic diseases through their treatment journey.

Sponsor:
  • Novartis Pharma AG
Prof. Jorge Sánchez
Listen now
Podcast

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Adis Journal Podcast/© Adis, Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images